ScienceDaily: Health & Medicine News |
- Novel targeted drug shows promise against advanced small cell lung cancer
- Nivolumab immunotherapy helps patients with advanced bladder cancer
- New drug 'retrains' immune system to fight aggressive bladder cancer
| Novel targeted drug shows promise against advanced small cell lung cancer Posted: 05 Jun 2016 09:41 AM PDT The experimental "smart-bomb" drug rovalpituzumab tesirine (Rova-T) appears safe and shows efficacy in treating patients with advanced small cell lung cancer, according to results from a first-in-human clinical trial. |
| Nivolumab immunotherapy helps patients with advanced bladder cancer Posted: 05 Jun 2016 09:41 AM PDT The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder cancer, regardless of whether their tumors had a biomarker related to the drug's target, according to clinical trial results. |
| New drug 'retrains' immune system to fight aggressive bladder cancer Posted: 05 Jun 2016 09:39 AM PDT A new drug that harnesses the immune system to attack tumors is highly effective against advanced bladder cancer, according to the results of an international clinical trial. |
| You are subscribed to email updates from Health & Medicine News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
ليست هناك تعليقات:
إرسال تعليق